Evaluating first-line immuno-oncology-based treatments for metastatic renal cell carcinoma in real world clinical practice using pre-treatment G8 scores

被引：0
|
作者：
Sazuka, Tomokazu [1 ]
Arai, Takayuki [1 ]
Sato, Hiroaki [1 ]
Goto, Yusuke [1 ]
Sakamoto, Shinichi [1 ]
Ichikawa, Tomohiko [1 ]
机构：
[1] Chiba Univ, Dept Urol, Grad Sch Med, Chiba, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2023年 / 30卷 / 11期
关键词：
D O I：
10.1111/iju.15249
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1054 / 1056
页数：3
相关论文
共 50 条
  • [21] ASSESSMENT OF EFFICACY, SAFETY AND QUALITY OF LIFE OF 110 PATIENTS TREATED WITH SUNITINIB AS FIRST-LINE THERAPY FOR METASTATIC RENAL CELL CARCINOMA: EXPERIENCE IN REAL WORLD CLINICAL PRACTICE IN JAPAN
    Harada, Ken-ichi
    Miyake, Hideaki
    Fujisawa, Masato
    JOURNAL OF UROLOGY, 2015, 193 (04): : E870 - E870
  • [22] Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?
    Bonadio, Renata Colombo
    Velho, Pedro Isaacsson
    Marta, Guilherme Nader
    Narda, Mirella
    La Souza, Manoel Carlos
    Muniz, David Q. B.
    Bezerra, Regis O. F.
    Bispo, Raisa K. A.
    Faraj, Sheila F.
    Bastos, Diogo A.
    Dzik, Carlos
    ECANCERMEDICALSCIENCE, 2019, 13
  • [23] Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies
    Sawaya, Ghady Bou-Nehme
    Dragomir, Alice
    Wood, Lori A.
    Kollmannsberger, Christian
    Basappa, Naveen S.
    Kapoor, Anil
    Soulieres, Denis
    Finelli, Antonio
    Heng, Daniel Y. C.
    Castonguay, Vincent
    Canil, Christina
    Winquist, Eric
    Graham, Jeffrey
    Bjarnason, Georg A.
    Bhindi, Bimal
    Lalani, Aly-Khan
    Pouliot, Frederic
    Breau, Rodney H.
    Saleh, Ramy
    Tanguay, Simon
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (03): : 570 - 580
  • [24] Editorial Comment to Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma Comment
    Tanaka, Hajime
    Fujii, Yasuhisa
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (08) : 822 - 823
  • [25] REAL-WORLD TREATMENT PATTERNS AMONG PATIENTS WITH METASTATIC RENAL CELL CARCINOMA RECEIVING FIRST-LINE THERAPY IN THE UNITED STATES VETERAN POPULATION
    Bhanegaonkar, A.
    Kim, R.
    Pandya, S.
    Wang, L.
    Krulewicz, S.
    Pennock, G.
    Phatak, H.
    VALUE IN HEALTH, 2019, 22 : S116 - S116
  • [26] Tivozanib as first-line treatment of metastatic renal cell carcinoma: A real-world outcome review in North-West of England, United Kingdom
    Wong, Sam
    Prasad, Kellati
    Waddell, Tom
    Charnley, Natalie
    Wong, Helen
    Law, Andrea
    Parikh, Omi
    Pillai, Manon
    Griffiths, Richard
    Chow, Shien
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [27] Clinical activity of immunotherapy-based combination first-line therapies for metastatic renal cell carcinoma: the right treatment for the right patient
    Borchiellini, Delphine
    Maillet, Denis
    BULLETIN DU CANCER, 2022, 109 (02) : S4 - S18
  • [28] Assessment of efficacy, safety and quality of life of 110 patients treated with sunitinib as first-line therapy for metastatic renal cell carcinoma: experience in real-world clinical practice in Japan
    Hideaki Miyake
    Akira Miyazaki
    Ken-ichi Harada
    Masato Fujisawa
    Medical Oncology, 2014, 31
  • [29] Assessment of efficacy, safety and quality of life of 110 patients treated with sunitinib as first-line therapy for metastatic renal cell carcinoma: experience in real-world clinical practice in Japan
    Miyake, Hideaki
    Miyazaki, Akira
    Harada, Ken-ichi
    Fujisawa, Masato
    MEDICAL ONCOLOGY, 2014, 31 (06)
  • [30] Outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with first-line Immuno-oncology (IO) agents who do not meet eligibility criteria for clinical trials.
    Gan, Chun Loo
    Dudani, Shaan
    Wells, Connor
    Bakouny, Ziad
    Dizman, Nazli
    Pal, Sumanta K.
    Szabados, Bernadett
    Wood, Lori
    Kollmannsberger, Christian K.
    Agarwal, Neeraj
    Donskov, Frede
    Basappa, Naveen S.
    Bjarnason, Georg A.
    Parnis, Francis
    Porta, Camillo
    Davis, Ian D.
    Vaishampayan, Ulka N.
    Kanesvaran, Ravindran
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345